Lv3
320 积分 2024-10-24 加入
Exploring the optimal chain length of modification module in disulfide bond bridged paclitaxel prodrug nanoassemblies for breast tumor treatment
8小时前
已完结
Self-engineered lipid peroxidation nano-amplifier for ferroptosis-driven antitumor therapy
9小时前
已完结
Emerging carrier‐free nanosystems based on molecular self‐assembly of pure drugs for cancer therapy
9小时前
已完结
Tandem‐Activatable PROTAC Prodrug for Tumor Biomarker‐Driven Near‐Infrared Opto‐Proteolysis
1天前
已完结
Exploring the optimal chain length of modification module in disulfide bond bridged paclitaxel prodrug nanoassemblies for breast tumor treatment
2天前
已完结
Engineered bioorthogonal POLY-PROTAC nanoparticles for tumour-specific protein degradation and precise cancer therapy
2天前
已完结
Exploiting targeted degradation of cyclins and cyclin-dependent kinases for cancer therapeutics: a review
6天前
已完结
In vivo self-assembled nano-PROTAC for the dual degradation of AR and HSP90 to overcome castration-resistant prostate cancer resistance
6天前
已完结
Engineering Metal‐Organic‐Framework‐Based STING Nanoagonists for PROTAC‐Enhanced Cancer Chemo‐Metalloimmunotherapy
6天前
已完结
p16-dependent increase of PD-L1 stability regulates immunosurveillance of senescent cells
10天前
已完结
皖公网安备34019202002308
